The US government, through the American Reinvestment and Recovery Act (ARRA), has allocated $8.2 billion in funding for extramural scientific research. Our goal is to keep you informed of upcoming NIH grants associated with this funding and to help provide the resources you need to apply. Many of the funding areas and topics specified are well served by Affymetrix' product portfolio. Our products include:

• GeneChip® Exon 1.0 ST and Gene 1.0 ST Arrays and reagents: whole-transcript gene expression microarrays for expression profiling studies and biomarker discovery
• New GeneChip® miRNA Solution: microRNA microarray, reagents, and QC software for gene expression regulation studies
• New Affymetrix® Cytogenetics Research Solutions: complete microarray solution for molecular cytogenetics research studies
• New DMET™ Plus Premier Pack: drug metabolism enzymes and transporter microarray and assay for ADME and pharmacogenomics studies
• New High-content, high-throughput next-generation genotyping microarrays for whole-genome association studies and copy number variation studies
• New GeneTitan™ System: instrument for automated microarray processing and data generation for high-end genomic analysis
• New QuantiGene® and QuantiGene Plex® Assays from Panomics: branch chain DNA-based gene expression assays for high-performance single and mid-plex biomarker validation for routine and difficult samples
• New QuantiGene® ViewRNA Assay from Panomics: in situ, multiplex transcription profiling
• New Procarta® Assays from Panomics: multiplexed cytokine and metalloprotease quantitation